The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Tumor Necrosis Factor Inhibitors May Slow the Progression of Spondyloarthritis

Tumor Necrosis Factor Inhibitors May Slow the Progression of Spondyloarthritis

November 16, 2021 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“You should be prepared to pull the trigger in these patients that much quicker when prescribing TNFi’s,” says Dr. Maksymowych. “Don’t waste time. … We certainly don’t want to see a patient developing ankylosis.”

You Might Also Like
  • Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors
  • Does Anti-Tumor Necrosis Factor-Alpha Increase Cardiovascular Burden?
  • EULAR 2014: Non-Tumor Necrosis Factor Biologics Update
Also By This Author
  • Patients with RA Who Respond to Treatment Experience Increased Cholesterol

Although Dr. Maksymowych points to findings on MRI, a consistent risk factor for disease severity that is affected by treatment and has been used as an outcome in clinical trials, he notes, generally, the field lacks risk factors for different stages of disease progression. “This is an area we think requires a lot more investigation and study,” he says. “We’re all looking for something that is a consistently strong predictor of radiographic progression.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Maksymowych especially emphasizes the need to validate surrogates for new bone formation, which can serve as early warning signals of ankylosis. This approach could be a test for gene expression or production of a protein that is consistently associated with radiographic progression and is more responsive to intervention than the mSASSS instrument used to monitor change on radiographs.


Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

References

  1. Kaaij MH, van Tok MN, Blijdorp IC, et al. Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis. J Exp Med. 2020. 217:e20200288.
  2. Sepriano A, Ramiro S, Wichuk S, et al. Tumor necrosis factor inhibitors reduce spinal radiographic progression in patients with radiographic axial spondyloarthritis: A longitudinal analysis from the Alberta Prospective Cohort. Arthritis Rheumatol. 2021 Jul;73(7):1211–1219.
  3. Bleil J, Maier R, Hempfing A, et al. Histomorphologic and histomorphometric characteristics of zygapophyseal joint remodeling in ankylosing spondylitis. Arthritis Rheumatol. 2014 Jul;66(7):1745–1754.
  4. Bleil J, Maier R, Hempfing A, et al. Granulation tissue eroding the subchondral bone also promotes new bone formation in ankylosing spondylitis. Arthritis Rheumatol. 2016 Oct;68(10):2456–2465.
  5. MC Hwang Ridley L, Reveille JD. Ankylosing spondylitis risk factors: a systematic literature review. Clin Rheumatol. 2021 Aug;40(8):3079–3093

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Spondyloarthritis Tagged With: axial spondyloarthritis (SpA), TNF, tumor necrosis factor (TNF) inhibitors, tumor necrosis factor inhibitor (TNFi)

You Might Also Like:
  • Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors
  • Does Anti-Tumor Necrosis Factor-Alpha Increase Cardiovascular Burden?
  • EULAR 2014: Non-Tumor Necrosis Factor Biologics Update
  • 2015 ACR/ARHP Annual Meeting: Role of Tumor Necrosis Factor Cytokines in Autoimmune Diseases Examined

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.